Treating and preventing HIV with generic drugs - Barriers in the United States Academic Article uri icon

Overview

MeSH Major

  • Anti-Retroviral Agents
  • Drug Costs
  • Drugs, Generic
  • HIV Infections

abstract

  • Most of the discussion about the availability of generic HIV drugs focuses on low- and middle-income countries. In the United States, numerous legal, clinical, and market factors create barriers to the adoption of generics as well as uncertainty about cost savings.

publication date

  • January 25, 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1056/NEJMp1710914

PubMed ID

  • 29365306

Additional Document Info

start page

  • 316

end page

  • 319

volume

  • 378

number

  • 4